- Home
- VRDN vs GNW Comparison
VRDN vs GNW Comparison
Compare VRDN & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | GNW |
|---|---|---|
| Founded | 2006 | 1871 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | VRDN | GNW |
|---|---|---|
| Price | $18.82 | $8.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $38.25 | $10.50 |
| AVG Volume (30 Days) | 1.8M | ★ 3.1M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | $5,706,000.00 | ★ $7,301,000,000.00 |
| Revenue This Year | $27.65 | N/A |
| Revenue Next Year | $253.29 | N/A |
| P/E Ratio | ★ N/A | $15.16 |
| Revenue Growth | N/A | ★ 0.08 |
| 52 Week Low | $9.90 | $5.99 |
| 52 Week High | $34.29 | $9.28 |
Technical Indicators
Market Signals| Indicator | VRDN | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 23.68 | 55.11 |
| Support Level | $17.91 | $8.30 |
| Resistance Level | $19.42 | $8.80 |
| Average True Range (ATR) | 1.12 | 0.20 |
| MACD | -1.02 | 0.04 |
| Stochastic Oscillator | 13.93 | 94.07 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.